Q: Good morning, please comment on WELL’s results. Cheers
5i Research Answer:
EPS of 3c beat estimates of 2.6c; revenue of $294M beat estimates of $285.9M. EBITDA of $27.6M matched estimates. Sales rose 32% and were a record. EBITDA rose 27%. Patient visits were 1.6 million, up 23%. Canadian clinics showed strength, and with Healwell included next quarter and 2025 results should show very good revenue growth. Guidance was largely in line with current analyst estimates. We would consider it a solid quarter overall.